Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination (2024)
Attributed to:
MICA: A bioequivalent study to WHO prequalify a new 15 mg primaquine tablet.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.60692/s6p63-m1s14
Publication URI: https://gresis.osc.int//doi/10.60692/s6p63-m1s14
Type: Other